Pituitary apoplexy natural history, complications and prognosis

Revision as of 15:08, 14 August 2017 by Akshun Kalia (talk | contribs)
Jump to navigation Jump to search

Pituitary apoplexy Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Pituitary apoplexy from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X-ray

Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Pituitary apoplexy natural history, complications and prognosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Pituitary apoplexy natural history, complications and prognosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Pituitary apoplexy natural history, complications and prognosis

CDC on Pituitary apoplexy natural history, complications and prognosis

Pituitary apoplexy natural history, complications and prognosis in the news

Blogs on Pituitary apoplexy natural history, complications and prognosis

Directions to Hospitals Treating Pituitary apoplexy

Risk calculators and risk factors for Pituitary apoplexy natural history, complications and prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Akshun Kalia M.B.B.S.[2]

Overview

If left untreated, pituitary apoplexy is an acute, life threatening condition. Pituitary apoplexy may lead to a sudden decline in pituitary hormone production. The most life threatening endocrinopathy is acute adrenal crisis. Complications of pituitary apoplexy include vision loss, optic neuritis, diplopia, ptosis, increased intracranial pressure, hypothyroidism, hypogonadism, and growth hormone deficiency. The prognosis of pituitary apoplexy depends upon presentation and initiation of therapy. Emergent application of medical and surgical treatment is associated with greater improvement in visual field defects, visual acuity, and diplopia. The outlook is good for people who are diagnosed early and treated. Patients require hormone(s) replacement therapy for life.

Natural History

If left untreated, pituitary apoplexy features depends upon the size of hemorrhage. Pituitary apoplexy is an acute, life threatening condition in case of massive hemorrhage. Pituitary apoplexy may lead to a sudden decline in pituitary hormone production. The most life threatening endocrinopathy is acute adrenal crisis. In case of small sized hemorrhage pituitary apoplexy may result in some temporary or permanent endocrinopathies from hypofunction of the pituitary gland.[1][2]

Complications

Complications of pituitary apoplexy can include:

Prognosis

Acute pituitary apoplexy can be life-threatening. The mortality rate associated with pituitary apoplexy is 12.5% and without treatment it can reach as high as 50%. Emergent application of medical and surgical treatment is associated with greater improvement in visual field defects, visual acuity, and diplopia. The outlook is good for people who are diagnosed early and treated. Patients require hormone(s) replacement therapy for life.[3][4][5][6]

References

  1. Woo HJ, Hwang JH, Hwang SK, Park YM (2010). "Clinical outcome of cranial neuropathy in patients with pituitary apoplexy". J Korean Neurosurg Soc. 48 (3): 213–8. doi:10.3340/jkns.2010.48.3.213. PMC 2966721. PMID 21082047.
  2. Baruah, ManashP; Ranabir, Salam (2011). "Pituitary apoplexy". Indian Journal of Endocrinology and Metabolism. 15 (7): 188. doi:10.4103/2230-8210.84862. ISSN 2230-8210.
  3. Xiao D, Wang S, Huang Y, Zhao L, Wei L, Ding C (2015). "Clinical analysis of infarction in pituitary adenoma". Int J Clin Exp Med. 8 (5): 7477–86. PMC 4509236. PMID 26221291.
  4. Nawar RN, AbdelMannan D, Selman WR, Arafah BM (2008). "Pituitary tumor apoplexy: a review". J Intensive Care Med. 23 (2): 75–90. doi:10.1177/0885066607312992. PMID 18372348.
  5. Randeva HS, Schoebel J, Byrne J, Esiri M, Adams CB, Wass JA (1999). "Classical pituitary apoplexy: clinical features, management and outcome". Clin. Endocrinol. (Oxf). 51 (2): 181–8. PMID 10468988.
  6. Murad-Kejbou S, Eggenberger E (2009). "Pituitary apoplexy: evaluation, management, and prognosis". Curr Opin Ophthalmol. 20 (6): 456–61. doi:10.1097/ICU.0b013e3283319061. PMID 19809320.

Template:WH Template:WS